Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Balance Sheet

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Balance Sheet History

[Consolidated]

Mar2023Mar2022Mar2013Mar2012
EQUITY AND LIABILITIES
Share Capital ₹19 Cr₹19 Cr₹16 Cr₹16 Cr
    Equity - Authorised ₹21 Cr₹21 Cr₹17 Cr₹17 Cr
    Equity - Issued ₹19 Cr₹19 Cr₹16 Cr₹16 Cr
    Equity Paid Up ₹19 Cr₹19 Cr₹16 Cr₹16 Cr
    Equity Shares Forfeited ----
    Adjustments to Equity ----
    Preference Capital Paid Up ----
    Face Value ₹10.00₹10.00₹10.00₹10.00
Share Warrants & Outstandings ----
Total Reserves ₹554 Cr₹523 Cr₹41 Cr₹30 Cr
    Securities Premium ₹134 Cr₹134 Cr--
    Capital Reserves ₹12 Cr₹12 Cr₹13 Cr₹13 Cr
    Profit & Loss Account Balance ₹406 Cr₹374 Cr₹26 Cr₹14 Cr
    General Reserves ₹2.97 Cr₹2.97 Cr₹2.97 Cr₹2.97 Cr
    Other Reserves ₹0.33 Cr₹0.30 Cr--
Reserve excluding Revaluation Reserve ₹554 Cr₹523 Cr₹41 Cr₹30 Cr
Revaluation reserve ----
Shareholder's Funds ₹573 Cr₹542 Cr₹57 Cr₹46 Cr
Minority Interest ₹-0.02 Cr₹-0.01 Cr--
Long-Term Borrowings ----
Secured Loans ₹0.40 Cr₹0.67 Cr₹1.05 Cr₹0.57 Cr
    Non Convertible Debentures ----
    Converible Debentures & Bonds ----
    Packing Credit - Bank ----
    Inter Corporate & Security Deposit ----
    Term Loans - Banks ----
    Term Loans - Institutions ----
    Other Secured ₹0.40 Cr₹0.67 Cr₹1.05 Cr₹0.57 Cr
Unsecured Loans --₹0.18 Cr₹0.20 Cr
    Fixed Deposits - Public ----
    Loans and advances from subsidiaries ----
    Inter Corporate Deposits (Unsecured) ----
    Foreign Currency Convertible Notes ----
    Long Term Loan in Foreign Currency ----
    Loans - Banks ----
    Loans - Govt. ----
    Loans - Others ----
    Other Unsecured Loan --₹0.18 Cr₹0.20 Cr
Deferred Tax Assets / Liabilities --₹-0.90 Cr₹-0.86 Cr
    Deferred Tax Assets --₹0.90 Cr₹0.86 Cr
    Deferred Tax Liability ----
Other Long Term Liabilities ----
Long Term Trade Payables ----
Long Term Provisions ₹2.79 Cr₹2.61 Cr₹1.47 Cr₹1.41 Cr
Total Non-Current Liabilities ₹3.19 Cr₹3.28 Cr₹1.79 Cr₹1.32 Cr
Current Liabilities ----
Trade Payables ₹28 Cr₹43 Cr₹28 Cr₹16 Cr
    Sundry Creditors ₹28 Cr₹43 Cr₹28 Cr₹16 Cr
    Acceptances ----
    Due to Subsidiaries- Trade Payables ----
Other Current Liabilities ₹84 Cr₹58 Cr₹53 Cr₹47 Cr
    Bank Overdraft / Short term credit ----
    Advances received from customers ₹15 Cr₹16 Cr₹5.18 Cr₹11 Cr
    Interest Accrued But Not Due ----
    Share Application Money ----
    Current maturity of Debentures & Bonds ----
    Current maturity - Others ----
    Other Liabilities ₹69 Cr₹42 Cr₹48 Cr₹36 Cr
Short Term Borrowings ₹104 Cr₹92 Cr₹17 Cr₹8.17 Cr
    Secured ST Loans repayable on Demands ₹103 Cr₹90 Cr₹14 Cr₹1.16 Cr
    Working Capital Loans- Sec ----
    Buyers Credits - Unsec ----
    Commercial Borrowings- Unsec ----
    Other Unsecured Loans ₹1.03 Cr₹1.88 Cr₹3.42 Cr₹7.01 Cr
Short Term Provisions ₹0.87 Cr₹1.97 Cr₹0.29 Cr₹0.06 Cr
    Proposed Equity Dividend ----
    Provision for Corporate Dividend Tax ----
    Provision for Tax ₹0.28 Cr₹0.89 Cr₹0.10 Cr₹0.06 Cr
    Provision for post retirement benefits ----
    Preference Dividend ----
    Other Provisions ₹0.59 Cr₹1.08 Cr₹0.19 Cr-
Total Current Liabilities ₹216 Cr₹194 Cr₹98 Cr₹72 Cr
Total Liabilities ₹793 Cr₹739 Cr₹157 Cr₹119 Cr
ASSETS
Gross Block ₹270 Cr₹267 Cr₹77 Cr₹56 Cr
Less: Accumulated Depreciation ₹25 Cr₹22 Cr₹39 Cr₹35 Cr
Less: Impairment of Assets ----
Net Block ₹244 Cr₹245 Cr₹38 Cr₹21 Cr
Lease Adjustment A/c ----
Capital Work in Progress ----
Non Current Investments ₹5.05 Cr₹5.05 Cr₹0.00 Cr₹0.51 Cr
Long Term Investment ₹5.05 Cr₹5.05 Cr₹0.00 Cr₹0.51 Cr
    Quoted ----
    Unquoted ₹5.05 Cr₹5.05 Cr₹0.00 Cr₹0.51 Cr
Long Term Loans & Advances ₹23 Cr₹22 Cr-₹1.50 Cr
Other Non Current Assets ----
Total Non-Current Assets ₹272 Cr₹272 Cr₹38 Cr₹23 Cr
Current Assets Loans & Advances ----
Currents Investments ----
    Quoted ----
    Unquoted ----
Inventories ₹208 Cr₹220 Cr₹77 Cr₹66 Cr
    Raw Materials ----
    Work-in Progress ₹191 Cr₹190 Cr₹68 Cr₹60 Cr
    Finished Goods ----
    Packing Materials ----
    Stores Ā and Spare ₹5.61 Cr₹6.12 Cr₹4.34 Cr₹3.78 Cr
    Other Inventory ₹11 Cr₹25 Cr₹5.12 Cr₹2.08 Cr
Sundry Debtors ₹97 Cr₹86 Cr₹21 Cr₹12 Cr
    Debtors more than Six months ₹18 Cr₹62 Cr₹5.07 Cr₹4.02 Cr
    Debtors Others ₹87 Cr₹30 Cr₹17 Cr₹9.61 Cr
Cash and Bank ₹38 Cr₹4.18 Cr₹2.48 Cr₹3.29 Cr
    Cash in hand ₹0.04 Cr₹0.05 Cr₹0.07 Cr₹0.07 Cr
    Balances at Bank ₹38 Cr₹4.13 Cr₹2.41 Cr₹3.22 Cr
    Other cash and bank balances ----
Other Current Assets ₹0.37 Cr₹0.40 Cr₹1.81 Cr₹0.46 Cr
    Interest accrued on Investments ----
    Interest accrued on Debentures ----
    Deposits with Government ----
    Interest accrued and or due on loans ₹0.01 Cr₹0.05 Cr-₹0.00 Cr
    Prepaid Expenses ₹0.36 Cr₹0.35 Cr₹0.15 Cr₹0.11 Cr
    Other current_assets --₹1.67 Cr₹0.35 Cr
Short Term Loans and Advances ₹177 Cr₹157 Cr₹17 Cr₹14 Cr
    Advances recoverable in cash or in kind ₹260 Cr₹239 Cr₹13 Cr₹10 Cr
    Advance income tax and TDS ₹6.05 Cr₹6.89 Cr₹3.06 Cr₹3.28 Cr
    Amounts due from directors ----
    Due From Subsidiaries ----
    Inter corporate deposits ----
    Corporate Deposits ----
    Other Loans & Advances ₹-88 Cr₹-89 Cr₹0.78 Cr₹0.81 Cr
Total Current Assets ₹521 Cr₹468 Cr₹120 Cr₹96 Cr
Net Current Assets (Including Current Investments) ₹304 Cr₹273 Cr₹22 Cr₹24 Cr
Miscellaneous Expenses not written off ----
Total Assets ₹793 Cr₹739 Cr₹157 Cr₹119 Cr
Contingent Liabilities ₹72 Cr₹61 Cr₹0.34 Cr₹0.26 Cr
Total Debt ₹105 Cr₹93 Cr₹19 Cr₹11 Cr
Book Value --35.9128.57
Adjusted Book Value 301.61285.1635.9128.57

Compare Balance Sheet of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹381.0 Cr 0.8% -15.2% 27.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,022.2 Cr 1.9% -9.3% 86.3% Stock Analytics
KAVERI SEED COMPANY ₹3,884.7 Cr -1.5% -5.4% 22.2% Stock Analytics
VENKYS (INDIA) ₹2,477.9 Cr -0.4% -13.5% -1.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹2,310.2 Cr NA -11.6% -31.3% Stock Analytics
TIERRA AGROTECH ₹449.7 Cr 3.7% -21.5% -47.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

0.8%

-15.2%

27.9%

SENSEX

0.5%

1.4%

23.5%


You may also like the below Video Courses